Publications 2013

Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tonnesen P, Suso EMI, Saeboe-Larssen S, Sandberg C, Brinchmann JE, Helseth E, Rasmussen AM, Lote K, Aamdal S, Gaudernack G, Kvalheim G, Langmoen IA (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Cancer Immunol. Immunother., 62 (9), 1499-1509
DOI 10.1007/s00262-013-1453-3

Publications 2012

Inderberg-Suso EM, Trachsel S, Lislerud K, Rasmussen AM, Gaudernack G (2012)
Widespread CD4(+) T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
OncoImmunology, 1 (5), 670-686
DOI 10.4161/onci.20426

Publications 2011

Almasbak H, Rian E, Hoel HJ, Pule M, Walchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2011)
Transiently redirected T cells for adoptive transfer
Cytotherapy, 13 (5), 629-640
DOI 10.3109/14653249.2010.542461

Hunger RE, Lang KK, Markowski CJ, Trachsel S, Moller M, Eriksen JA, Rasmussen AM, Braathen LR, Gaudernack G (2011)
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
Cancer Immunol. Immunother., 60 (11), 1553-1564
DOI 10.1007/s00262-011-1061-z

Suso EMI, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Cancer Immunol. Immunother., 60 (6), 809-818
DOI 10.1007/s00262-011-0991-9

Publications 2010

Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
J. Immunol. Methods, 355 (1-2), 52-60
DOI 10.1016/j.jim.2010.02.004